Free shipping on all orders over $ 500

 About 1 result found for searched term "915296-00-3" (0.118 seconds)

Cat.No.  Name Target
M22514 Elotuzumab Others
BMS 901608; PDL 063; HuLuc 63
Elotuzumab is a First-in-Class monoclonal antibody directed against the SLAMF7 receptor, it specifically binds to signaling lymphocyte activating molecule family member 7 (SLAMF7) and activates the body's immune response to attack and kill multiple myeloma cells. Elotuzumab exerts its anti-myeloma effects mainly through ADCC and activation of NK cells.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.